CKD Corporation carries a market capitalization of 499.93B, placing it among publicly traded companies globally. Its enterprise value stands at 203.69B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 499.93B |
| Enterprise Value | 203.69B |
CKD Corporation currently has 66.77M shares outstanding.
| Shares Outstanding | 66.77M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
CKD Corporation trades at a trailing price-to-earnings ratio of 44.91. The price-to-sales ratio is 2.90, and the price-to-book ratio stands at 1.89.
| PE Ratio | 44.91 |
| PS Ratio | 2.90 |
| PB Ratio | 1.89 |
| P/TBV Ratio | 1.51 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
On an enterprise value basis, CKD Corporation trades at an EV/EBITDA multiple of 28.87 and an EV/FCF ratio of 1,039.91. The EV/Sales ratio of 3.00 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 28.87 provides insight into valuation relative to core operating earnings.
| EV / Sales | 3.00 |
| EV / EBITDA | 28.87 |
| EV / EBIT | 28.87 |
| EV / FCF | 1,039.91 |
CKD Corporation maintains a current ratio of 2.97, meaning it holds 3.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 26.79, indicating elevated leverage, while an interest coverage ratio of 23.06 demonstrates strong ability to service its debt obligations.
| Current Ratio | 2.97 |
| Quick Ratio | 0.65 |
| Debt / Equity | 26.79 |
| Debt / EBITDA | 4.99 |
| Interest Coverage | 23.06 |
CKD Corporation posts a return on equity of 4.36 and a return on invested capital of 2.72.
| Return on Equity (ROE) | 4.36 |
| Return on Assets (ROA) | 2.12 |
| Return on Invested Capital (ROIC) | 2.72 |
| Return on Capital Employed (ROCE) | 3.35 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 0.83 |
Over the trailing twelve months, CKD Corporation has paid 2.46B in income taxes, reflecting an effective tax rate of 35.99.
| Income Tax | 2.46B |
| Effective Tax Rate | 35.99 |
CKD Corporation's stock has gained approximately 189.81015% over the past 52 weeks. The 50-day moving average sits at 6,743.80, while the 200-day moving average is 4,536.97.
| Beta (5Y) | N/A |
| 52-Week Price Change | 189.81015% |
| 50-Day Moving Average | 6,743.80 |
| 200-Day Moving Average | 4,536.97 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, CKD Corporation generated 67.91B in revenue and converted that into 4.38B in net income, yielding earnings per share of 65.57. EBITDA reached 7.06B, while operating income came in at 7.06B.
| Revenue | 67.91B |
| Gross Profit | 19.50B |
| Operating Income | 7.06B |
| Pretax Income | 6.84B |
| Net Income | 4.38B |
| EBITDA | 7.06B |
| EBIT | 7.06B |
| Earnings Per Share (EPS) | 65.57 |
CKD Corporation holds 28.12B in cash and equivalents against 35.22B in total debt, resulting in a net debt position of 7.10B. Total book value stands at 104.01B, with working capital of 84.85B providing operational flexibility.
| Cash & Cash Equivalents | 28.12B |
| Total Debt | 35.22B |
| Net Debt | 7.10B |
| Equity (Book Value) | 104.01B |
| Book Value Per Share | 1,558.07 |
| Working Capital | 84.85B |
CKD Corporation operates with a gross margin of 28.71, reflecting its pricing power and cost economics. The operating margin of 10.39 and net profit margin of 6.45 provide insight into operational efficiency.
| Gross Margin | 28.71 |
| Operating Margin | 10.39 |
| Pretax Margin | 10.07 |
| Profit Margin | 6.45 |
| EBITDA Margin | 10.39 |
CKD Corporation posts an Altman Z-Score of 3.08, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 3.08 |